Biocompatibility evaluation of lactide--trimethylene carbonate copolymers.
- Author:
Song TU
1
;
Jian YANG
;
Yuanwei CHEN
;
Xianglin LUO
;
Suming LI
Author Information
1. College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, China.
- Publication Type:Journal Article
- MeSH:
Absorbable Implants;
Biocompatible Materials;
chemistry;
metabolism;
Blood Platelets;
cytology;
Hardness;
Humans;
Lactic Acid;
chemistry;
metabolism;
Materials Testing;
Polyesters;
chemistry;
metabolism;
Polymers;
chemistry;
metabolism;
Tissue Engineering;
methods
- From:
Journal of Biomedical Engineering
2010;27(3):595-599
- CountryChina
- Language:Chinese
-
Abstract:
Biocompatibility is the essential property of biomaterials, which is the essence of biomaterial evaluation as well as the foundation of the design and improvement of biomaterials. Several methods were carried out to evaluate the biocompatibility of poly(L-Lactide)-b-poly(trimethylene carbonate (PLLA-b-PTMC) and poly(D,L-Lactide)-b-poly(trimethylene carbonate) (PDLLA-b-PTMC) with poly(L-Lactide) (PLLA) and poly(trimethylene carbonate) (PTMC) as control, including extract liquid experiment, directly contact experiment of materials and cells, hemolytic ratio analysis and platelet adhesion investigation. The results revealed that all the materials exhibited an acceptable cytotoxicity, and proliferation of cells on the modified materials was less than that on the PLLA but more than that on PTMC. The results of hemocompatibility experiments showed that no significant hemolysis was detected when all the materials were in use; in addition, the numbers of platelets adhered on the surface of copolymers were smaller than that on the surface of PLLA, and the degree of platelet deformation was slighter. So, the biocompatibility of copolymers is similar to that of PLLA, the biocompatibility of PLLA is not remarkably changed by modification with PTMC, but rather is improved.
